UNSPSC 51286400: Antibacterial piperidines

This classification denotes antibacterials based on the (CH2)5NH structure.

UNSPSC 51286400 Antibacterial piperidines is a Class code with minimal recent state and local procurement activity aligned to its nominal scope. The solicitations tagged under this code do not materially involve antibacterial piperidine compounds; instead, they span emergency medical supplies, naloxone and drug deactivation systems, generic pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer pharmacy benefit program design. The mismatch between the code's chemical specificity and the breadth of actual procurements suggests either tagging inconsistency in issuing systems or that this code functions as a catch-all for pharmaceutical and medical supply categories that do not map neatly to narrower UNSPSC endpoints. State and local buyers soliciting under this code include county health systems (Seminole County, Florida), municipal fire and rescue departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP).

Recent opportunities span the Southeast and Upper Midwest, with visible activity in Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with a response deadline of July 26, 2023 (note the date inconsistency in source). The City of Tampa released ITB 26P00145 on March 25, 2026, for medical and first aid supplies for the Tampa Fire Department Rescue Division—169 line items with an estimated contract value of $700,000, designated as a sheltered market opportunity with a 5 percent bid discount for certified Small Local Business Enterprises, and a response deadline of March 13, 2026. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas HHS Commission released RFI HHS0017013 on April 3, 2026, as a market intelligence tool to inform a future direct-to-manufacturer pharmacy prescription program, with no formal award timeline or budget specified in this exploratory phase.